Page last updated: 2024-08-24

tirofiban and Ventricular Dysfunction, Left

tirofiban has been researched along with Ventricular Dysfunction, Left in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boyle, AJ; Danelich, IM; Entwistle, JW; Kabadi, RA; Marhefka, GD; Qureshi, AM; Reeves, G1
Ballesteros Ortega, D; Blancas Gómez-Casero, R; Castro Gallego, O; Chana García, M; Estébanez Montiel, B; López Matamala, B; Marina Martínez, L; Martín Parra, C; Martínez González, O; Prieto Valderrey, F; Quintana Díaz, M; Vigil Escribano, D1
Akpinar, I; Aydin, M; Dogan, SM; Elri, T; Karabag, T; Salihoglu, YS; Sayin, MR1
Baglini, R; Berra Centurini, P; Capuano, C; Danzi, GB; Mauri, L; Sesana, M1

Trials

1 trial(s) available for tirofiban and Ventricular Dysfunction, Left

ArticleYear
Comparison in patients having primary coronary angioplasty of abciximab versus tirofiban on recovery of left ventricular function.
    The American journal of cardiology, 2004, Jul-01, Volume: 94, Issue:1

    Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Coronary Angiography; Echocardiography; Female; Humans; Immunoglobulin Fab Fragments; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Tirofiban; Treatment Outcome; Tyrosine; Ventricular Dysfunction, Left

2004

Other Studies

3 other study(ies) available for tirofiban and Ventricular Dysfunction, Left

ArticleYear
Use of Cangrelor as a Bridge to Left Ventricular Assist Device Implantation in a Patient with a Recent Drug-Eluting Stent Who Developed Acute Tirofiban-Related Thrombocytopenia.
    Pharmacotherapy, 2019, Volume: 39, Issue:4

    Topics: Adenosine Monophosphate; Angioplasty, Balloon, Coronary; Dose-Response Relationship, Drug; Drug-Eluting Stents; Heart-Assist Devices; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Thrombocytopenia; Tirofiban; Treatment Outcome; Ventricular Dysfunction, Left

2019
[Influence of the combination of antiplatelet agents on the occurrence of early left ventricular insufficiency in patients with acute coronary syndromes without persistent ST-segment elevation].
    Medicina clinica, 2014, Apr-07, Volume: 142, Issue:7

    Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Aspirin; Clopidogrel; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Prospective Studies; Risk Factors; Ticlopidine; Tirofiban; Treatment Outcome; Tyrosine; Ventricular Dysfunction, Left

2014
Tirofiban in Takotsubo cardiomyopathy. Atypical broken heart syndrome with extremely fast recovery: a case report.
    Herz, 2013, Volume: 38, Issue:1

    Topics: Female; Humans; Middle Aged; Platelet Aggregation Inhibitors; Recovery of Function; Takotsubo Cardiomyopathy; Tirofiban; Treatment Outcome; Tyrosine; Ventricular Dysfunction, Left

2013